SCM Lifescience Co., Ltd. (KOSDAQ: 298060)

SCM Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	226.99	4,496	6,916	2,890	77.47	4,435
Short-Term Investments	6,321	7,840	2,053	16,754	35,219	19,584
Cash & Short-Term Investments	6,548	12,336	8,970	19,644	35,297	24,019
Cash Growth	133.81%	37.52%	-54.34%	-44.35%	46.95%	-37.61%
Accounts Receivable	198.6	106.41	5.63	16.8	18.59	14.39
Other Receivables	1.53	19.91	19.7	72.87	59.18	153.8
Receivables	200.13	126.32	25.34	89.66	77.77	168.19
Inventory	452.82	392.06	102.71	279.68	36.02	309.55
Prepaid Expenses	156.81	264.78	227.82	223	311.73	198.14
Other Current Assets	131.44	141.25	714.15	75.52	363.66	138.88
Total Current Assets	7,489	13,260	10,040	20,312	36,086	24,834
Property, Plant & Equipment	10,104	10,254	10,650	11,117	11,544	11,266
Long-Term Investments	1,085	1,085	11,468	21,654	28,167	4,439
Other Intangible Assets	747.84	236.93	302.73	335.32	359.17	375.74
Other Long-Term Assets	1,016	567.69	559.11	627.01	136.21	121.83
Total Assets	20,442	25,404	33,020	54,045	76,292	41,037
Accounts Payable	2.35	-	-	-	-	-
Accrued Expenses	170.13	180.44	107.3	232.79	224.61	178.16
Short-Term Debt	-	-	2,000	-	-	-3,017
Current Portion of Long-Term Debt	-	-	-	5,820	120	120
Current Portion of Leases	240.4	131.05	61.56	269.68	330.72	431.12
Other Current Liabilities	762.63	836.73	2,393	2,387	2,584	13,083
Total Current Liabilities	1,176	1,148	4,562	8,709	3,259	10,795
Long-Term Debt	3,630	3,630	3,630	-	5,820	5,940
Long-Term Leases	244.19	57.02	77.55	81.12	368.64	648.07
Other Long-Term Liabilities	419.71	95.01	239.21	641.8	3,765	239.69
Total Liabilities	5,469	4,930	8,509	9,432	13,213	17,623
Common Stock	10,234	10,234	6,060	6,011	5,937	4,586
Additional Paid-In Capital	178,689	178,514	163,098	161,784	160,144	103,877
Retained Earnings	-176,663	-170,987	-147,026	-124,096	-101,577	-91,944
Treasury Stock	-16.56	-16.56	-	-	-	-
Comprensive Income & Other	2,730	2,730	2,378	913.54	-1,425	331.15
Total Common Equity	14,973	20,474	24,511	44,613	63,079	16,851
Shareholders' Equity	14,973	20,474	24,511	44,613	63,079	23,414
Total Liabilities & Equity	20,442	25,404	33,020	54,045	76,292	41,037
Total Debt	4,115	3,818	5,769	6,171	6,639	4,122
Net Cash (Debt)	2,433	8,518	3,201	13,473	28,658	19,897
Net Cash Growth	-	166.12%	-76.24%	-52.99%	44.03%	30.20%
Net Cash Per Share	118.64	520.43	220.68	1126.01	2701.30	3779.45
Filing Date Shares Outstanding	20.46	20.46	14.54	14.43	14.25	9.22
Total Common Shares Outstanding	20.46	20.46	14.54	14.43	14.25	9.22
Working Capital	6,313	12,112	5,478	11,602	32,827	14,039
Book Value Per Share	731.79	1000.63	1685.22	3092.46	4426.77	1828.38
Tangible Book Value	14,225	20,237	24,208	44,277	62,720	16,475
Tangible Book Value Per Share	695.24	989.05	1664.40	3069.22	4401.57	1787.61
Land	6,967	6,967	6,967	6,967	6,967	6,967
Buildings	2,117	2,117	2,117	2,117	2,114	1,068
Machinery	3,590	3,561	3,472	3,318	2,762	2,485
Construction In Progress	-	640.2	577.31	304.92	293.57	223.87

Source: S&P Capital IQ. Standard template. Financial Sources.